Brucine Inhibits Proliferation of Pancreatic Ductal Adenocarcinoma through PI3K/AKT Pathway-induced Mitochondrial Apoptosis.
Yiqi DuFenglin ZhangPanling XuPing LiPublished in: Current cancer drug targets (2024)
Overall, these findings suggest that brucine has therapeutic potential as a remedy option for PDAC.